Tvardi Therapeutics Inc. TVRD
NASDAQ · United States · Health Technology
$1.15-0.09 (-7.26%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -0.69 | -0.70 | +2.1% | $0 | — | +5.1%$1.77→$1.86 |
| Q1 2026 | 2026-05-08 | -0.73 | -0.65 | -12.3% | — | — | -5.9%$4.21→$3.96 |
| Q4 2025 | 2026-03-31 | -0.78 | -0.57 | -36.8% | — | — | -6.3%$3.20→$3.00 |
| Q3 2025 | 2025-11-13 | -0.59 | -0.83 | +28.9% | — | — | -5.0%$4.24→$4.03 |
| Q1 2025 | 2025-05-13 | -0.50 | -0.58 | +13.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.